skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:064144/0699   Pages: 3
Recorded: 06/27/2023
Conveyance: ASSIGNEE CHANGE OF ADDRESS
Total properties: 11
1
Patent #:
NONE
Issue Dt:
Application #:
10716183
Filing Dt:
11/18/2003
Publication #:
Pub Dt:
08/26/2004
Title:
Bis-aryl sulfonamides
2
Patent #:
NONE
Issue Dt:
Application #:
11255163
Filing Dt:
10/20/2005
Publication #:
Pub Dt:
05/25/2006
Title:
Aryl sulfonamides
3
Patent #:
NONE
Issue Dt:
Application #:
15408896
Filing Dt:
01/18/2017
Publication #:
Pub Dt:
07/20/2017
Title:
2-OXINDOLE COMPOUNDS
4
Patent #:
NONE
Issue Dt:
Application #:
15596278
Filing Dt:
05/16/2017
Publication #:
Pub Dt:
11/16/2017
Title:
DEUTERATED HETEROARYL SULFONAMIDES AND THEIR USE
5
Patent #:
NONE
Issue Dt:
Application #:
15720513
Filing Dt:
09/29/2017
Publication #:
Pub Dt:
02/01/2018
Title:
POLYMORPHIC FORMS OF THE SODIUM SALT OF 4-TERT- BUTYL -N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENE SULFONAMIDE
6
Patent #:
NONE
Issue Dt:
Application #:
16358311
Filing Dt:
03/19/2019
Publication #:
Pub Dt:
09/12/2019
Title:
COMBINATION THERAPY USING A CHEMOKINE RECEPTOR 2 (CCR2) ANTAGONIST AND A PD-1/PD-L1 INHIBITOR
7
Patent #:
NONE
Issue Dt:
Application #:
17064550
Filing Dt:
10/06/2020
Publication #:
Pub Dt:
05/27/2021
Title:
Compositions and Methods for Treating CCR9-Mediated Diseases using CCR9 Inhibitor and Anti-TNF-Alpha Blocking Antibodies
8
Patent #:
Issue Dt:
01/09/2024
Application #:
17071056
Filing Dt:
10/15/2020
Publication #:
Pub Dt:
05/06/2021
Title:
HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES
9
Patent #:
Issue Dt:
08/01/2023
Application #:
17071077
Filing Dt:
10/15/2020
Publication #:
Pub Dt:
05/06/2021
Title:
HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES
10
Patent #:
Issue Dt:
07/25/2023
Application #:
17106309
Filing Dt:
11/30/2020
Publication #:
Pub Dt:
05/20/2021
Title:
IMMUNOMODULATOR COMPOUNDS
11
Patent #:
NONE
Issue Dt:
Application #:
17267937
Filing Dt:
02/11/2021
Publication #:
Pub Dt:
08/05/2021
Title:
METHODS OF TREATING CANCER WITH SMALL MOLECULE PD-L1 INHIBITORS
Assignor
1
Exec Dt:
06/23/2023
Assignee
1
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CALIFORNIA 91320-1799
Correspondence name and address
AMGEN INC.
ONE AMGEN CENTER DRIVE
MAIL STOP 28-5-A
THOUSAND OAKS, CA 91320-1799

Search Results as of: 05/29/2024 11:28 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT